Symbiosis Pharmaceutical Services Limited

Stirling, United KingdomFEI 3009864467API manufacture registered

Symbiosis Pharmaceutical Services Limited is a drug establishment in Stirling, United Kingdom, registered with the US FDA under FEI 3009864467. Its registered operations are: Analytical testing, API manufacture, Drug manufacture. 8 EU/UK GMP certificates are matched to this site, 6 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testingAPI manufactureDrug manufacture

GMP documents matched to this site (8)

DocumentAuthorityInspectionSource
UK MIA(IMP) 40211 Insp IMP 40211/37423042-0004[I]
GMP certificate
MHRA4 Feb 2025
within 3-year review window
MHRA-GMDP
UK MIA(IMP) 40211 Insp IMP 40211/405290-0019[I]
GMP certificate
MHRA4 Feb 2025
within 3-year review window
MHRA-GMDP
UK MIA 40211 Insp GMP 40211/37423042-0005[H]
GMP certificate
MHRA4 Feb 2025
within 3-year review window
MHRA-GMDP
UK MIA 40211 Insp GMP 40211/405290-0020[H]
GMP certificate
MHRA4 Feb 2025
within 3-year review window
MHRA-GMDP
UK MIA(IMP) 40211 Insp IMP 40211/33209260-0005[I]
GMP certificate
MHRA20 Aug 2024
within 3-year review window
MHRA-GMDP
UK MIA 40211 Insp GMP 40211/33209260-0006[H]
GMP certificate
MHRA20 Aug 2024
within 3-year review window
MHRA-GMDP
UK GMP 40211 Insp GMP/IMP 40211/33209260-0001 [H]
GMP certificate
MHRA8 Sept 2023
outside 3-year review window
MHRA-GMDP
UK GMP 40211 Insp GMP/IMP 40211/33209260-0001 [V]
GMP certificate
MHRA8 Sept 2023
outside 3-year review window
MHRA-GMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.